AIM ImmunoTech prices USD 2.65 million registered direct offering at USD 0.52 a share

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc. Common Stock

AIM

0.00
  • AIM ImmunoTech priced a registered direct offering and concurrent private placement to raise about $2.65 million in gross proceeds.
  • Registered direct offering: 2,554,119 common shares at USD 0.52 per share; expected to close around June 10, 2026.
  • Private placement: 2,554,119 unregistered common shares or pre-funded warrants at USD 0.52; Class J warrants for up to 10,216,476 shares.
  • Class J warrants carry a USD 0.52 exercise price, require stockholder approval to exercise, expire five years from initial exercise date.
  • Proceeds earmarked for clinical drug supply manufacturing, ongoing and planned Phase 3 trial activities, working capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AIM ImmunoTech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606090929PRIMZONEFULLFEED9734039) on June 09, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.